• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
    • Cardiovascular
    • Orthopedics
  • Wall Street Beat
    • Funding Roundup
    • Mergers & Acquisitions
  • Podcasts
    • MPR: Breakthrough Products Series
  • Resources
    • About MassDevice
    • Newsletter Signup
    • Job Board
    • Leadership in Medtech
    • Manufacturer Search
    • MedTech 100 Index
    • Videos
    • Whitepapers
  • DeviceTalks Tuesdays
    • DeviceTalks
  • Coronavirus: Live updates

Haemonetics

Haemonetics posts Street-beating Q3 results

February 4, 2020 By Danielle Kirsh

Haemonetics (NYSE:HAE) posted third-quarter results today that beat the consensus forecast on Wall Street and reaffirmed its total revenue guidance. The news sent shares in HAE up more than 9%. The Boston-based company reported profits of $29.9 million, or 58¢ per share, on sales of $259 million for the three months ended Dec. 31, 2019, for […]

Filed Under: Wall Street Beat Tagged With: Haemonetics

Haemonetics buys hemostasis analyzer IP

January 14, 2020 By Sean Whooley

Haemonetics (NYSE:HAE) announced today that it purchased the technology underlying the TEG 6s hemostasis analyzer system from CoraMed Technologies. Braintree, Mass.-based Haemonetics now owns the intellectual property it previously licensed from CoraMed for use in hospitals and hospital laboratories, and may pursue site-of-care opportunities beyond hospitals. TEG 6s includes an analyzer, disposable cartridges and software designed […]

Filed Under: Blood Management, Business/Financial News, Mergers & Acquisitions Tagged With: CoraMed, Haemonetics

Haemonetics opens new Boston headquarters

December 12, 2019 By Danielle Kirsh

Haemonetics (NYSE:HAE) said this week it opened its new global headquarters in Boston. The new location will help the company bring together its corporate and commercial teams with its research and development organization. “Relocating our headquarters to Boston is an important step in Haemonetics’ transformation,” president and CEO Chris Simon said. “Our new downtown location in […]

Filed Under: Business/Financial News Tagged With: Haemonetics

Haemonetics (HAE) launches SafeTrace Tx in North America

December 5, 2019 By Sean Whooley

Haemonetics (NYSE:HAE) announced that it commercially launched the next generation of its SafeTrace TX transfusion management software in North America. SafeTrace TX is a specialized transfusion management system used in the blood bank for managing patient and blood product information and assisting in determining blood product suitability for patient transfusion. The updated software is designed to […]

Filed Under: Blood Management, Business/Financial News Tagged With: Haemonetics

Haemonetics beats Wall Street on Q1 EPS, revenue

August 6, 2019 By Nancy Crotti

Haemonetics (NYSE:HAE) posted first-quarter 2020 results today that beat the consensus forecast on Wall Street and boosted its fiscal 2020 EPS guidance. The Braintree, Mass.-based medical device maker reported a loss of -$8.48million, or -$0.17 per share, on sales of $238.5 million for the three months ended June 29, 2019, for a bottom-line loss of […]

Filed Under: Blog, Business/Financial News, Featured, News Well, Wall Street Beat Tagged With: Haemonetics

Haemonetics wins expanded FDA nod for TEG 6s hemostasis analyzer

May 15, 2019 By Fink Densford

Haemonetics (NYSE:HAE) said on Monday that it won expanded FDA 510(k) clearance for its TEG 6s hemostasis analyzer system, now indicated for use in adult trauma settings. The TEG 6s system is comprised of an analyzer, disposable cartridges and software and is intended to provide a rapid and accurate identification of a patient’s hemostasis condition, the […]

Filed Under: 510(k), Blood Management, Food & Drug Administration (FDA), Regulatory/Compliance Tagged With: Haemonetics

Haemonetics deals S.C. plant to CSL Plasma for $10m

May 14, 2019 By Brad Perriello

Haemonetics (NYSE:HAE) said today that it agreed to sell a plant in South Carolina to CSL Plasma for $10 million. The Union, S.C., facility makes the liquid saline and sodium citrate solutions used in plasma collection. CSL Plasma, the supplier for CSL Behring, will own and operate the plant, taking on “substantially all” of the roughly […]

Filed Under: Blood Management, Featured, Mergers & Acquisitions, Wall Street Beat Tagged With: Haemonetics

Haemonetics shares fall on Q3 sales miss

February 5, 2019 By Fink Densford

Shares in Haemonetics (NYSE:HAE) have fallen nearly 10% today after the medical device maker posted fiscal year 2019 third quarter earnings that topped earnings per share estimates but missed sales consensus on Wall Street. The Braintree, Mass.-based company posted profits of approximately $18.3 million, or 35¢ per share, on sales of approximately $247.4 million for the […]

Filed Under: Business/Financial News, Featured, MassDevice Earnings Roundup, Wall Street Beat Tagged With: Haemonetics

10 of the best performing medical device stocks of 2018

January 8, 2019 By Nancy Crotti

Updated Jan. 8, 2019 Medical device company stocks are not looking as rosy as they did two months ago, but the medtech industry still appears to be resisting the overall downward trend in stock markets, according to a Medical Design & Outsourcinganalysis. More than half of the roughly 100 largest medical device companies in the world […]

Filed Under: Business/Financial News, Featured, News Well Tagged With: Abiomed, AtriCure Inc., Boston Scientific, CryoLife, Dexcom, Edwards Lifesciences, Haemonetics, Insulet, integer, Intuitive Surgical

Haemonetics relocates HQ to downtown Boston

December 20, 2018 By Fink Densford

Haemonetics (NYSE:HAE) said yesterday it plans to relocate to downtown Boston from its previous home in Braintree, Mass. The move will position the blood-focused device developer in a 62,000 square-foot of space at 125 Summer Street, the company said, and will allow it to sell its 17-acre Braintree campus. “We’re excited to welcome Haemonetics to 125 Summer Street as we […]

Filed Under: Business/Financial News, Featured Tagged With: Haemonetics

Haemonetics post Street-beating FY 2019 Q2

November 7, 2018 By Fink Densford

Shares in Haemonetics (NYSE:HAE) have risen today after the medical device maker posted fiscal year 2019 second quarter earnings that topped expectations on Wall Street and lifted its guidance for the remaining 2019 fiscal year. The Braintree, Mass.-based company posted profits of $18.7 million, or 35¢ per share, on sales of approximately $241.6 million for the […]

Filed Under: Business/Financial News, MassDevice Earnings Roundup, Wall Street Beat Tagged With: Haemonetics

  • « Go to Previous Page
  • Go to page 1
  • Go to page 2
  • Go to page 3
  • Go to page 4
  • Interim pages omitted …
  • Go to page 11
  • Go to Next Page »

Primary Sidebar

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Need Medtech news in a minute?
We Deliver!

MassDevice Enewsletters get you caught up on all the mission critical news you need in med tech. Sign up today.

Tweets by @MassDevice
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion

MASSDEVICE

Subscribe to MassDevice
Advertise with us
About
Contact us

Add us on Facebook Follow us on Twitter Connect with us on LinkedIn Follow us on YouTube

Copyright © 2021 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy | RSS